Результаты 3-летнего проспективного наблюдения за больными с хронической сердечной недостаточностью после трансплантации мононуклеарных клеток костного мозга
А. Т. Тепляков, Ахмедов Шамиль Джаманович, Elena V. Grakova et al. · Сибирский медицинский журнал (Томск) · 2012
Clinical and functional assessment of 66 patients with coronary artery disease and postinfarction dysfunction after mononuclear marrow cells transplantation in longterm prospective study (3, 6, 12, 36 months) is presented. The present study involves 38 cases of coronary artery bypass grafting (САВО) with singlestep cells transplantation and 28 people composed the control group (САВО without cells transplantation). Assessment of physical tolerance, life quality and left ventricular remodeling are given in dynamics. We have registered regress of angina and functional class of heart failure, improvement of life quality, physical tolerance and myocardial perfusion after 6 months in the main group. High clinical efficiency and trend to the growth of the left ventricular ejection fraction (EF) (in 19%; р
Cited by 0 works.
Authors
- А. Т. Тепляков
- Ахмедов Шамиль Джаманович
- Elena V. Grakova
- Кистенева Ирина Валерьевна
- Ю. Ю. Торим
- Буховец Ирина Львовна
- Irina Nikolaevna Vorozhtsova
- Т. Е. Суслова
References
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
- Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
- Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
- Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
- Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction
- Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure